Shchipanova A I, Maĭchuk Iu F, Nikolaeva I S, Pershin G N
Farmakol Toksikol. 1981 Jul-Aug;44(4):439-42.
A study was made on the pharmacokinetics in rabbit eye tissues of a new antiviral drug riodoksol in the form of ointment and biosoluble eye films. The pharmacokinetics of the drug was studied in eye tissues of normal rabbits and in those infected with herpes simplex virus. It was disclosed that four-fold application of 0.25% ointment produced the therapeutic concentration of the drug only in the cornea. Application of eye films made it possible to attain the therapeutic concentrations of riodoksol in the cornea and, within the first 3 hours, in the iris and humor of the anterior chamber. No differences were found in the drug concentrations in the tissues of intact and infected animals. Appraisal of the therapeutic efficacy of riodoksol regimens devised in experimental surface herpetic keratitis of rabbits has shown an adequacy of a single administration of eye films containing 0.5 mg of the substance and four-fold application of 0.25% ointment.
对一种新型抗病毒药物碘多克索(以软膏和生物可溶眼膜形式)在兔眼组织中的药代动力学进行了研究。在正常兔眼组织以及感染单纯疱疹病毒的兔眼组织中研究了该药物的药代动力学。结果显示,四倍涂抹0.25%的软膏仅在角膜中产生药物治疗浓度。应用眼膜能够在角膜中达到碘多克索的治疗浓度,并且在前3小时内在虹膜和前房房水中也能达到。在未感染和感染动物的组织中未发现药物浓度有差异。对在兔实验性表层疱疹性角膜炎中设计的碘多克索给药方案的治疗效果评估表明,单次应用含0.5毫克该物质的眼膜和四倍涂抹0.25%的软膏是足够的。